MetLife Investment Advisors »

Enanta Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $97k 10k 9.41
2023-09-30 $116k 10k 11.17
2023-06-30 $221k 10k 21.40
2023-03-31 $418k 10k 40.44
2022-12-31 $481k 10k 46.52
2022-09-30 $536k 10k 51.84
2022-06-30 $518k 11k 47.27
2022-03-31 $780k 11k 71.18
2021-12-31 $510k 6.8k 74.78
2021-09-30 $387k 6.8k 56.81
2021-06-30 $365k 8.3k 44.01
2021-03-31 $409k 8.3k 49.32
2020-12-31 $349k 8.3k 42.08
2020-09-30 $380k 8.3k 45.78
2020-06-30 $416k 8.3k 50.16
2020-03-31 $427k 8.3k 51.43
2019-12-31 $469k 7.6k 61.78
2019-09-30 $457k 7.6k 60.08
2019-06-30 $641k 7.6k 84.36
2019-03-31 $726k 7.6k 95.52
2018-12-31 $538k 7.6k 70.83
2018-09-30 $1.0M 12k 85.49
2018-06-30 $881k 7.6k 115.95
2018-03-31 $615k 7.6k 80.94
2017-12-31 $446k 7.6k 58.70